DOP007 Efficacy of vedolizumab induction therapy on clinical and endoscopic activity in patients with anti-tumour necrosis factor alpha-resistant inflammatory bowel disease

Tumour Necrosis Factor ◽

Induction Therapy ◽

Bowel Disease ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

TUBERCULOSIS IN INFLAMMATORY BOWEL DISEASE UNDER TUMOUR NECROSIS FACTOR ALPHA ANTAGONIST – THE RISK BEYOND SCREENING

10.26226/morressier.59a6b34bd462b80290b559b1 ◽

2017 ◽

Author(s):

Carvalho Liliana

Keyword(s):

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Alpha Antagonist ◽

Maternal and foetal adverse events with tumour necrosis factor-alpha inhibitors in inflammatory bowel disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12936 ◽

2014 ◽

Vol 40 (9) ◽

pp. 1035-1043 ◽

Cited By ~ 21

Author(s):

P. Deepak ◽

D. J. Stobaugh

Keyword(s):

Adverse Events ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjv042 ◽

2015 ◽

Vol 9 (5) ◽

pp. 382-389 ◽

Cited By ~ 5

Author(s):

K. Karmiris ◽

P. Bossuyt ◽

D. Sorrentino ◽

T. Moreels ◽

A. Scarcelli ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Cerebrovascular Events ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Osteonecrosis of the jaw in patients with inflammatory bowel disease treated with tumour necrosis factor alpha inhibitors

International Journal of Oral and Maxillofacial Surgery ◽

10.1016/j.ijom.2019.08.007 ◽

2020 ◽

Vol 49 (3) ◽

pp. 317-324 ◽

Cited By ~ 3

Author(s):

K. Brijs ◽

I. Miclotte ◽

S. Vermeire ◽

V. Darche ◽

C. Politis

Keyword(s):

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Osteonecrosis Of The Jaw ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2007.03553.x ◽

2007 ◽

Vol 27 (1) ◽

pp. 19-30 ◽

Cited By ~ 69

Author(s):

V. S. THEIS ◽

J. M. RHODES

Keyword(s):

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Review Article ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.

Gut ◽

10.1136/gut.34.12.1705 ◽

1993 ◽

Vol 34 (12) ◽

pp. 1705-1709 ◽

Cited By ~ 331

Author(s):

S H Murch ◽

C P Braegger ◽

J A Walker-Smith ◽

T T MacDonald

Keyword(s):

Bowel Disease ◽

Tumour Necrosis ◽

Chronic Inflammatory Bowel Disease ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor ◽

Chronic Inflammatory Bowel

Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Anti-tumour Necrosis Factor Alpha Agents: A Systematic Review and Meta-analysis

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjy065 ◽

2018 ◽

Cited By ~ 2

Author(s):

Chen Yang ◽

Junlin Huang ◽

Xiaowen Huang ◽

Shaozhuo Huang ◽

Jiaxin Cheng ◽

...

Keyword(s):

Systematic Review ◽

Bowel Disease ◽

Tumour Necrosis ◽

Meta Analysis ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies

Scandinavian Journal of Gastroenterology ◽

10.1080/00365520802699278 ◽

2009 ◽

Vol 44 (7) ◽

pp. 774-781 ◽

Cited By ~ 110

Author(s):

Klaus Bendtzen ◽

Mark Ainsworth ◽

Casper Steenholdt ◽

Ole Østergaard Thomsen ◽

Jørn Brynskov

Keyword(s):

Bowel Disease ◽

Tumour Necrosis ◽

Disease Monitoring ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Individual Medicine ◽

Tumour necrosis factor-alpha concentrations in whole gut lavage fluid do not represent disease activity in inflammatory bowel disease

The Netherlands Journal of Medicine ◽

10.1016/0300-2977(96)89595-7 ◽

1996 ◽

Vol 48 (1) ◽

pp. A18-A19

Author(s):

P KRUMM ◽

A VANDIJK ◽

C TAK ◽

F ZIJLSTRA ◽

M VANBLANKENSTEIN ◽

...

Keyword(s):

Bowel Disease ◽

Tumour Necrosis ◽

Lavage Fluid ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor ◽

Gut Lavage

Prospective study to assess tumour necrosis factor alpha in non-inflammatory bowel disease enterocutaneous fistula

International Journal of Surgery ◽

10.1016/j.ijsu.2013.06.020 ◽

2013 ◽

Vol 11 (8) ◽

pp. 589-590

Author(s):

Goher Rahbour ◽

Hafid O. Al-Hassi ◽

Ailsa L. Hart ◽

Muhammad R. Ullah ◽

Simon M. Gabe ◽

...

Keyword(s):

Prospective Study ◽

Bowel Disease ◽

Tumour Necrosis ◽

Enterocutaneous Fistula ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽